Zobrazeno 1 - 10
of 1 290
pro vyhledávání: '"Lanman RB"'
Autor:
Lanman RB; Institute for Historical Ecology, Los Altos, California, United States of America., Batter TJ; Elk and Pronghorn Program, Big Game Unit, Wildlife Branch, California Department of Fish and Wildlife, West Sacramento, California, United States of America., Mckee CJ; Elk and Moose Program, Game Division, Nevada Department of Wildlife, Reno, Nevada, United States of America.
Publikováno v:
PloS one [PLoS One] 2024 Sep 18; Vol. 19 (9), pp. e0301665. Date of Electronic Publication: 2024 Sep 18 (Print Publication: 2024).
Autor:
Baumgartner JM; Department of Surgery, Division of Surgical Oncology, University of California, San Diego, La Jolla, CA, USA. j1baumgartner@ucsd.edu., Riviere P; Center for Personalized Cancer Therapy, University of California, San Diego, La Jolla, CA, USA., Lanman RB; Guardant Health, Inc., Redwood City, CA, USA., Kelly KJ; Department of Surgery, Division of Surgical Oncology, University of California, San Diego, La Jolla, CA, USA., Veerapong J; Department of Surgery, Division of Surgical Oncology, University of California, San Diego, La Jolla, CA, USA., Lowy AM; Department of Surgery, Division of Surgical Oncology, University of California, San Diego, La Jolla, CA, USA., Kurzrock R; Center for Personalized Cancer Therapy, University of California, San Diego, La Jolla, CA, USA.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2020 Sep; Vol. 27 (9), pp. 3259-3267. Date of Electronic Publication: 2020 Aug 06.
Autor:
Ezeife DA; Department of Oncology, Tom Baker Cancer Center, 1331 29 St NW, Toronto, ON T2N 4N2, Canada University of Calgary, Calgary, AB, Canada., Spackman E; University of Calgary, Calgary, AB, Canada., Juergens RA; Juravinski Cancer Center, McMaster University, Hamilton, ON, Canada., Laskin JJ; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Agulnik JS; Jewish General Hospital, McGill University, Montreal, QC, Canada., Hao D; Tom Baker Cancer Center, Calgary, AB, Canada University of Calgary, Calgary AB, Canada., Laurie SA; Ottawa Hospital Research Institute/Department of Medicine, University of Ottawa, Ottawa, ON, Canada., Law JH; Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Le LW; Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Kiedrowski LA; Guardant Health, Inc., Redwood City, CA, Canada., Melosky B; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Shepherd FA; Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Cohen V; Jewish General Hospital, McGill University, Montreal, QC, Canada., Wheatley-Price P; Ottawa Hospital Research Institute/Department of Medicine, University of Ottawa, Ottawa, ON, Canada., Vandermeer R; Niagara Health, St. Catharines, ON, Canada., Li JJ; Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Fernandes R; Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada., Shokoohi A; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Lanman RB; Guardant Health, Inc., Redwood City, CA, Canada., Leighl NB; Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Jul 26; Vol. 14, pp. 17588359221112696. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).
Autor:
Ikeda, S, Tsigelny, IF, Skjevik, AA, Kono, Y, Mendler, M, Kuo, A, Sicklick, JK, Heestand, G, Banks, KC, Talasaz, A, Lanman, RB, Lippman, S, Kurzrock, R
Publikováno v:
The oncologist, vol 23, iss 5
Ikeda, S; Tsigelny, IF; Skjevik, AA; Kono, Y; Mendler, M; Kuo, A; et al.(2018). Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. ONCOLOGIST, 23(5), 586-593. doi: 10.1634/theoncologist.2017-0479. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/1kw8n456
Ikeda, S; Tsigelny, IF; Skjevik, AA; Kono, Y; Mendler, M; Kuo, A; et al.(2018). Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. ONCOLOGIST, 23(5), 586-593. doi: 10.1634/theoncologist.2017-0479. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/1kw8n456
BACKGROUND:Because imaging has a high sensitivity to diagnose hepatocellular carcinoma (HCC) and tissue biopsies carry risks such as bleeding, the latter are often not performed in HCC. Blood-derived circulating tumor DNA (ctDNA) analysis can identif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0d38f2c37e433fd9f96bc0669d00a8be
https://escholarship.org/uc/item/1kw8n456
https://escholarship.org/uc/item/1kw8n456
Autor:
Carneiro, BA, Collier, KA, Nagy, RJ, Pamarthy, S, Sagar, V, Fairclough, S, Odegaard, J, Lanman, RB, Costa, R, Taxter, T, Kuzel, TM, Fan, A, Chae, YK, Cristofanilli, M, Hussain, MH, Abdulkadir, SA, Giles, FJ
PARP1/2 inhibitors are effective against BRCA2-deficient tumors. The PARP inhibitor (PARPi) olaparib received FDA breakthrough designation for treatment of metastatic castration-resistant prostate cancers (CRPC) carrying mutations in BRCA1/2 or ATM g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmc_________::0362328964ff9825aae15e061b49137c
https://europepmc.org/articles/PMC6732782/
https://europepmc.org/articles/PMC6732782/
Autor:
Lapin M; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Huang HJ; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Chagani S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Javle M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Shroff RT; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Division of Hematology/Oncology, University of Arizona Cancer Center, Tucson, AZ., Pant S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Gouda MA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Raina A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Madwani K; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Holley VR; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Call SG; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Dustin DJ; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Lanman RB; Guardant Health, Redwood City, CA., Meric-Bernstam F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX., Raymond VM; Guardant Health, Redwood City, CA., Kwong LN; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Janku F; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2022 Feb; Vol. 6, pp. e2100197.
Autor:
Page RD; Center for Cancer and Blood Disorders, Fort Worth, TX., Drusbosky LM; Guardant Health, Inc, Redwood City, CA. Electronic address: ldrusbosky@gmail.com., Dada H; Guardant Health, Inc, Redwood City, CA., Raymond VM; Guardant Health, Inc, Redwood City, CA., Daniel DB; Tennessee Oncology, Chattanooga, TN., Divers SG; Genesis Cancer Center, Hot Springs, AR., Reckamp KL; Cedars-Sinai Medical Center, Los Angeles, CA., Villalona-Calero MA; Miami Cancer Institute, Miami, FL., Dix D; Guardant Health, Inc, Redwood City, CA., Odegaard JI; Guardant Health, Inc, Redwood City, CA., Lanman RB; Guardant Health, Inc, Redwood City, CA., Papadimitrakopoulou VA; U of Texas, MD Anderson Cancer Center, Houston, TX; Pfizer, Inc, New York, NY., Leighl NB; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2022 Jan; Vol. 23 (1), pp. 72-81. Date of Electronic Publication: 2021 Oct 10.
Autor:
Palmero R; ICO Bellvitge, Hospitalet Llobregat/Spain., Taus A; Hospital del Mar, Barcelona, Spain.; Universidad Autónoma de Barcelona (UAB), Barcelona, Spain., Viteri S; Quirón Salud-Dexeus University Institute, IOR, Medical Oncology Department, Barcelona, Spain., Majem M; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Carcereny E; Institut Català d'Oncologia Badalona-Hospital Germans Trias i Pujol B-ARGO, Badalona, Spain., Garde-Noguera J; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Felip E; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Nadal E; ICO Bellvitge, Hospitalet Llobregat/Spain., Malfettone A; Medica Scientia Innovation Research-MEDSIR, Barcelona, Spain and Ridgewood, NJ., Sampayo M; Medica Scientia Innovation Research-MEDSIR, Barcelona, Spain and Ridgewood, NJ., Riva F; Medica Scientia Innovation Research-MEDSIR, Barcelona, Spain and Ridgewood, NJ., Nagy RJ; Guardant Health, South San Francisco, CA., Lanman RB; Guardant Health, South San Francisco, CA., Faull I; Guardant Health, South San Francisco, CA., Dix D; Guardant Health, South San Francisco, CA., Karachaliou N; Catalan Institute of Oncology, Hospital Germans Trias I Pujol, Badalona, Spain., Rosell R; Catalan Institute of Oncology, Hospital Germans Trias I Pujol, Badalona, Spain.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2021 Nov; Vol. 5, pp. 93-102.
Autor:
Collisson, Eric, Lanman, RB, Mortimer, SA, Zill, OA, Sebisanovic, D, Lopez, R, Blau, S, Collisson, EA, Divers, SG, Hoon, DSB, Scott, E
Publikováno v:
Collisson, Eric; Lanman, RB; Mortimer, SA; Zill, OA; Sebisanovic, D; Lopez, R; et al.(2015). Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/2967n1gx
© 2015 Lanman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::52553b1ae3fbbe590e51b4efec292f76
http://www.escholarship.org/uc/item/2967n1gx
http://www.escholarship.org/uc/item/2967n1gx
Autor:
Kingston B; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Cutts RJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Bye H; Centre for Molecular Pathology, Royal Marsden Hospital, London, UK., Beaney M; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Walsh-Crestani G; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Hrebien S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Swift C; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Kilburn LS; ICR-CTSU, The Institute of Cancer Research, London, UK., Kernaghan S; ICR-CTSU, The Institute of Cancer Research, London, UK., Moretti L; ICR-CTSU, The Institute of Cancer Research, London, UK., Wilkinson K; ICR-CTSU, The Institute of Cancer Research, London, UK., Wardley AM; NIHR Manchester Clinical Research Facility at The Christie, Manchester Academic Health Science Centre & Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine & Health, University of Manchester, Manchester, UK., Macpherson IR; The Beatson West of Scotland Cancer Centre, Glasgow, UK., Baird RD; Cancer Research UK Cambridge Centre, Cambridge, UK., Roylance R; University College London Hospitals NHS Foundation Trust, London, UK., Reis-Filho JS; Memorial Sloan Kettering Cancer Centre, New York, NY, USA., Hubank M; Centre for Molecular Pathology, Royal Marsden Hospital, London, UK., Faull I; Guardant Health, Inc., Redwood City, CA, USA., Banks KC; Guardant Health, Inc., Redwood City, CA, USA., Lanman RB; Guardant Health, Inc., Redwood City, CA, USA., Garcia-Murillas I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Bliss JM; ICR-CTSU, The Institute of Cancer Research, London, UK., Ring A; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, UK. Alistair.ring@rmh.nhs.uk., Turner NC; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. nicholas.turner@icr.ac.uk.; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, UK. nicholas.turner@icr.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Jul 16; Vol. 12 (1), pp. 4479. Date of Electronic Publication: 2021 Jul 16.